COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy

por Jaber, Aliya, Patel, Meera, Sylvester, Andrew, Yarussi, Mary, Kalina, J. Tamar, Mendoza, Jason P., Avila, Robin L., Tremblay, Matthew A.
Publicado 2023

Refractory Statin-Induced Immune-Mediated Necrotizing Myositis: Challenges and Perils in Its Management

por Yeo, Chong Hsien, Yaakub, Aziman, Wang, Margaret Choon Lee, Shim, Sylvester Andrew, Chong, Pui L, Khalil, Muhammad Abdul Mabood, Telisinghe, Pemasiri U, Lim, Kian C, Tan, Jackson, Chong, Vui H
Publicado 2022